Prolongation of Midazolam Half-Life After Sustained Infusion for Status Epilepticus
Neurol 54:1366-1368, Naritoku,D.K.&Sinha,S., 2000
Long-Term outcome in Patients With Guillain-Barre Syndrome Requiring Mechanical Ventilation
Neurol 54:2311-2315, Fletcher,D.D.,et al, 2000
Factor V Leiden and Antiphospholipid Antibodies Are Significant Risk Factors for Ischemic Stroke in Children
Stroke 31:1283-1288, Kenet,G.,et al, 2000
Intravenous tPA in Acute Ischemic Stroke Related to Internal Carotid Artery Dissection
Neurol 54:2159-2161, Derex,L.,et al, 2000
Systematic Comparison of the Early Outcome of Angioplasty and Endarterectomy for Symptomatic Carotid Artery Disease
Stroke 31:1439-1443, Golledge,J.,et al, 2000
Identification of lacunar Infarcts Before Thrombolysis in the ECASS I Study
Neurol 54:684-688, Toni,D.,et al, 2000
Effect of Endovascular Services and Hospital Volume on Cerebral Aneurysm Treatment Outcomes
Stroke 31:111-117, Johnston,S.C., 2000
rtPA Intravenous Thrombolysis in Anterior Choroidal Artery Territory Stroke
Neurol 54:666-673, Trouillas,P.,et al, 2000
Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke in Patients Aged 80 Years and Older, The tPa Stroke Survey Experience
Stroke 31:370-375, Tanne,D.,et al, 2000
Treating Acute Stroke Patients with Intravenous tPA, The OSF Stroke Network Experience
Stroke 31:77-81, Wang,D.Z.,et al, 2000
Elective Stenting of Symptomatic Basilar Artery Stenosis
Stroke 31:95-99, Gomez,C.R.,et al, 2000
Most Commonly Asked Questions About Carotid Angioplasty and Stenting
The Neurologist 6:58-61, Cates,C.U., 2000
Identification of Patients at Risk for Periprocedural Neurological Deficits Associated with Carotid Angioplasty and Stenting
Stroke 31:376-382, Qureshi,A.I.,et al, 2000
Pharmacologic Paralysis and Withdrawal of Mechanical Ventilation at the End of Life
NEJM 342:508-511, Truog,R.D.,et al, 2000
Endovascular Treatment of Ruptured Posterior Circulation Cerebral Aneurysms, Clinical and Angiographic Outcomes
Stroke 31:100-110, Lempert,T.E.,et al, 2000
Treatment of Atherosclerotic Disease at the Cervical Carotid Bifurcation: Current Status and Review of the Literature
AJNR 21:444-450, Connors III,J.J.,et al, 2000
Arterial Dissections Complicating Cerebral Angiography and Cerebrovascular Interventions
AJNR 21:541-545, Cloft,H.J.,et al, 2000
Stroke Treatment with Tissue Plasminogen Activator in the Setting of Aortic Dissection
Neurol 54:1010, Fessler,A.J. & Alberts,M.J., 2000
Neurological Emergencies: Acute Stroke
JNNP 68:277-288, Davenport,R. & Dennis,M., 2000
Intravenous Tissue-Type Plasminogen Activator for Treatment of Acute Stroke
JAMA 283:1145-1150,1189, Albers,G.W.,et al, 2000
Use of Tissue-Type Plasminogen Activator for Acute Ischemic Stroke
JAMA 283:1151-1158,1189, Katzan,I.L.,et al, 2000
Short-Term Arteriographic and Clinical Outcome After Cerebral Angioplasty and Stenting for Intracranial Vertebrobasilar and Carotid ATherosclerotic Occlusive Disease
AJNR 21:249-254, Mori,T.,et al, 2000
Immune Cytopenias as the Presenting Finding in Primary Sjogrens Syndrome
QJM 93:825-829, Schattner,A.,et al, 2000
Expanding the Window for Thrombolytic Therapy in Acute Stroke, The Potential Role of Acute MRI for Patient Selection
Stroke 30:2230-2237, Albers,G.W., 1999
MRI Features of Intracerebral Hemorrhage Within 2 Hours from Symptom Onset
Stroke 30:2263-2267, Linfante,I.,et al, 1999
Recombinant Tissue-Type Plasminogen Activator (Alteplase) for Ischemic Stroke 3 to 5 Hours After Symptom Onset, The ATLANTIS Study:A Randomized Controlled Trial
JAMA 282:2019-2026, Clark,W.M.,et al, 1999
Clinicopath Conf,Thrombosis of St. Jude Medical Aortic Valve,Intra-Cerebral Lobar Hemorrhage, Case 37-1999
NEJM 341:1829-1835, , 1999
Mechanisms and Clinical Features of Posterior Border-Zone Infarcts
Neurol 53:1312-1318, Belden,J.R.,et al, 1999
Treatment and Secondary Prevention of Stroke:Evidence, Costs, and Effects on Individuals and Populations
Lancet 354:1457-1463, Hankey,G.J.&Warlow,C.P., 1999
Silent Embolism in Diagnostic Cerebral Angiography and Neurointerventional Procedures:A Prospective Study
Lancet 354:1594-1597,1577, Bendszus,M.,et al, 1999
Frequency and Determinants of Postprocedural Hemodynamic Instability after Carotid Angioplasty and Stenting
Stroke 30:2086-2093, Qureshi,A.I.,et al, 1999
Treatment of Posterior Circulation Ischemia with Extracranial Percutaneous Balloon Angioplasty and Stent Placement
Stroke 30:2073-2085, Malek,A.M.,et al, 1999
Balloon Angioplasty for Embolic Total Occlusion of the Middle Cerebral Artery and Ipsilateral Carotid Stenting in an Acute Stroke Stage
AJNR 20:1462-1464,1389, Mori,T.,et al, 1999
Intracranial Deployment of Coronary Stents for Symptomatic Atherosclerotic Disease
AJNR 20:1688-1694, Morris,P.P.,et al, 1999
Fatal Cerebral Reperfusion Hemorrhage after Carotid Stenting
Stroke 30:2483-2486, McCabe,D.J.H.,et al, 1999
Subclavian Artery Stenosis Caused by Non-Specific Arteritis (Takayasu Disease):Treatment with Palmaz Stent
Eur J Radiol 31:193-196, Maskovic,J.,et al, 1999
MR Angiography with Three-Dimensional Time-of-Flight and Targeted Maximum-Intensity-Projection Reconstructions in the Follow-up of Intracranial Aneurysms Embolized with Guglielmi Detachable Coils
AJNR 20:1470-1475,1391, Kahara,V.J.,et al, 1999
Is the Routine Use of Intravenous Immunoglobulin Treatment in Neurologic Disorders Justified?
Arch Neurol 56:1028-1032, Karussis,D.&Abramsky,O., 1999
Do Patients with Obstructive Sleep Apnea Wake up with Headaches?
Arch Int Med 159:1765-1768, Loh,N.K.,et al, 1999
Tracheostomy, In Guillain- Barre Syndrome
Muscle & Nerve 22:1058-1062, Lawn,N.D.&Wijdicks,E.F.M., 1999
Intracranial Internal Carotid Artery Angioplasty:Technique with Clinical and Radiographic Results and Follow-Up
AJR 172:703-707, Eckard,D.A.,et al, 1999
Postoperative Outcome of 37 Patients with Lobar Intracerebral Hemorrhage Related to Cerebral Amyloid Angiopathy
Stroke 30:29-33, Izumihara,A.,et al, 1999
Diagnosis and Treatment of Ischemic Stroke
Am J Med 106:211-221, Alberts,M.J., 1999
Association of Hyperdense Middle Cerebral Artery Sign with Clinical Outcome in Patients Treated with Tissue Plasminogen Activator
Stroke 30:769-772, Manelfe,C.,et al, 1999
Arteriovenous Malformations of the Brain in Adults
NEJM 340:1812-1818, The Arteriovenous Malformation Study Group, 1999
Which Unruptured Cerebral Aneurysms Should be Treated? A Cost-Utility Analysis
Neurol 52:1806-1815, Johnston,S.C.,et al, 1999
Surgical and Endovascular Treatment of Unruptured Cerebral Aneurysms at University Hospitals
Neurol 52:1799-1805, Johnston,S.C.,et al, 1999
Evaluation of Early Reperfusion and IV tPA Therapy Using Diffuion- and Perfusion-Weighted MRI
Neurol 52:1792-1798,1733, Marks,M.P.,et al, 1999
Effects of Tissue Plasminogen Activator for Acute Ischemic Stroke at One Year
NEJM 340:1781-1787, Kwiatkowski,T.G.,et al, 1999
Applications of Diffusion-Perfusion Magnetic Resonance Imaging in Acute Ischemic Stroke
Neurol 52:1750-1756,1733, Fisher,M.&Albers,G.W., 1999